首页> 美国卫生研究院文献>OncoTargets and therapy >Efficacy of pemetrexed plus platinum doublet chemotherapy as first-line treatment for advanced nonsquamous non-small-cell-lung cancer: a systematic review and meta-analysis

【2h】

Efficacy of pemetrexed plus platinum doublet chemotherapy as first-line treatment for advanced nonsquamous non-small-cell-lung cancer: a systematic review and meta-analysis

机译：培美曲塞联合铂金双重化疗作为晚期非鳞状非小细胞肺癌一线治疗的疗效：系统评价和荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeTo assess the efficacy of pemetrexed plus platinum doublet chemotherapy as first-line treatment for advanced nonsquamous non-small-cell lung cancer (NSCLC) through a trial-level meta-analysis.

机译：目的通过试验水平的荟萃分析评估培美曲塞加铂金双联化疗作为晚期非鳞状非小细胞肺癌（NSCLC）一线治疗的疗效。

著录项

期刊名称 OncoTargets and therapy
作者
Huai-Qing Xiao; Rong-Hua Tian; Zhi-Hao Zhang; Kai-Qi Du; Yi-Ming Ni;
展开▼
作者单位

展开▼
年(卷),期 2016(9),-1
年度 2016
页码 1471–1476
总页数 6
原文格式 PDF
正文语种
中图分类应用微生物学;肿瘤学;
关键词
chemotherapy-naive lung cancer pemetrexed pooled analysis randomized controlled trials;

机译：单纯化疗;肺癌;培美曲塞;汇总分析;随机对照试验;

相似文献

外文文献
中文文献
专利

1. Efficacy of pemetrexed plus platinum doublet chemotherapy as first-line treatment for advanced nonsquamous non-small-cell-lung cancer: a systematic review and meta-analysis [J] . Huai-Qing Xiao, Rong-Hua Tian, Zhi-Hao Zhang, OncoTargets and therapy . 2016,第3期

机译：培美曲塞联合铂金双重化疗作为晚期非鳞状非小细胞肺癌一线治疗的疗效：系统评价和荟萃分析
2. Comparative Effectiveness of Pemetrexed-platinum Doublet Chemotherapy With or Without Bevacizumab as First-line Therapy for Treatment naive Patients With Advanced Nonsquamous Non-small-cell Lung Cancer in China [J] . Li Xiaoyou, Abbas Muhammad, Li Yun, Clinical therapeutics . 2019,第3期

机译：磷酸铂双胞盆化疗的比较有效性与贝伐单抗作为中国治疗幼稚患者的一线治疗中国先进的非小细胞肺癌的一线治疗
3. AvaALL: Open-Label Randomized Phase 1Mb Trial Evaluating the Efficacy and Safety of Standard of Care With or Without Continuous Bevacizumab (BV) Treatment Beyond Disease Progression in Patients (pts) With Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) After First-Line (1L) Treatment With BV Plus Platinum-Doublet Chemotherapy (CT) [J] . Clinical advances in hematology & oncology: H&O . 2012,第Suppla11期

机译：AvaALL：开放标签随机1Mb临床试验，评估在初次手术后晚期非鳞状非小细胞肺癌（NSCLC）患者病情进展之外，是否进行持续贝伐单抗（BV）治疗的标准治疗的有效性和安全性BV加上铂金双线化疗（CT）的线（1L）治疗
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy [D] . 鈴木, 裕子 2019

机译：吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
6. Single pemetrexed is noninferior to platinum-based pemetrexed doublet as first-line treatment on elderly Chinese patients with advanced nonsquamous nonsmall cell lung cancer [O] . Xiaolin Pu, Wei Li, Binbin Lu, -1

机译：单药培美曲塞不逊于铂基培美曲塞双线药物作为中国老年晚期非鳞状非小细胞肺癌患者的一线治疗
7. Efficacy of pemetrexed plus platinum doublet chemotherapy as first-line treatment for advanced nonsquamous non-small-cell-lung cancer: a systematic review and meta-analysis [O] . Yi-Ming Ni, Huai-Qing Xiao, Rong-Hua Tian, 2016

机译：Pemetrexed Plus铂双重化疗作为先进的非小细胞肺癌的一线治疗疗效：系统评价和荟萃分析

Efficacy of pemetrexed plus platinum doublet chemotherapy as first-line treatment for advanced nonsquamous non-small-cell-lung cancer: a systematic review and meta-analysis

摘要

著录项

相似文献

相关主题

期刊订阅